Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments.
Guangdong Kanghua Healthcare Group Co's 3-Year RORE % for the quarter that ended in Dec. 2025 was -14.08%.
FRA:E9Q's 3-Year RORE % is ranked worse than 60.83% of 600
companies
in the Healthcare Providers & Services industry
Industry Median: 1.2
vs FRA:E9Q: -14.08
Guangdong Kanghua Healthcare Group Co (FRA:E9Q) 3-Year RORE % Explanation
Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.
There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.
Be Aware
Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.
Guangdong Kanghua Healthcare Group Co 3-Year RORE % Related Terms
Guangdong Kanghua Healthcare Group Co 3-Year RORE % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Guangdong Kanghua Healthcare Group Co 3-Year RORE % Chart
FRA:E9Q vs HCA, THC, DVA: 3-Year RORE % Comparison
For the Medical Care Facilities subindustry, Guangdong Kanghua Healthcare Group Co's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Guangdong Kanghua Healthcare Group Co 3-Year RORE % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Guangdong Kanghua Healthcare Group Co's 3-Year RORE % distribution charts can be found below:
* The bar in red indicates where Guangdong Kanghua Healthcare Group Co's 3-Year RORE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Dec. 2025 and 3-year before.
Guangdong Kanghua Healthcare Group Co (FRA:E9Q) has a 3-Year RORE % of -14.08 as of Dec. 2025. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Guangdong Kanghua Healthcare Group Co and its competitors. According to the industry distribution chart, Guangdong Kanghua Healthcare Group Co ranks #365 out of 600 companies in the Healthcare Providers & Services industry, placing it in the top 60.8%.
Is Guangdong Kanghua Healthcare Group Co's 3-Year RORE % too high?
Guangdong Kanghua Healthcare Group Co's current 3-Year RORE % is -14.08. Based on the distribution chart, Guangdong Kanghua Healthcare Group Co ranks #365 out of 600 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Guangdong Kanghua Healthcare Group Co has a GF Score™ of 79/100, reflecting its overall financial health beyond just this single metric.
How does Guangdong Kanghua Healthcare Group Co's 3-Year RORE % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Guangdong Kanghua Healthcare Group Co ranks #365 out of 600 companies for 3-Year RORE %. This places Guangdong Kanghua Healthcare Group Co in the lower half of its industry. The industry median 3-Year RORE % is 1.20. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year RORE % for a Healthcare Providers & Services company?
The median 3-Year RORE % among Healthcare Providers & Services companies is 1.20, based on 600 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year RORE % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year RORE % mean?
A high 3-Year RORE % can signal that a stock is expensive relative to its fundamentals. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Guangdong Kanghua Healthcare Group Co and its competitors. For the Healthcare Providers & Services industry, the median 3-Year RORE % is 1.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Guangdong Kanghua Healthcare Group Co's current 3-Year RORE % is -14.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guangdong Kanghua Healthcare Group Co stock overvalued right now?
Guangdong Kanghua Healthcare Group Co (FRA:E9Q) has a current 3-Year RORE % of -14.08. The stock's GF Value™ is €0.22, compared to a current price of €0.20 — trading 10% below its estimated fair value. The current 3-Year RORE % is -14.08. Guangdong Kanghua Healthcare Group Co's overall GF Score™ is 79/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year RORE % calculated?
3-Year RORE % is calculated from a company's financial statements. For Guangdong Kanghua Healthcare Group Co (FRA:E9Q), the current 3-Year RORE % is -14.08 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Guangdong Kanghua Healthcare Group Co (FRA:E9Q) Overvalued in 2026?
Based on GuruFocus' analysis, Guangdong Kanghua Healthcare Group Co stock appears to be undervalued.
The current stock price of €0.20 is trading 10% below its estimated GF Value™ of €0.22.
Key valuation signals for FRA:E9Q:
3-Year RORE %: -14.08
GF Value™: €0.22 vs. price of €0.20 (10% below fair value)
No single metric tells the full story. See the FRA:E9Q stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Guangdong Kanghua Healthcare Group Co Ltd provides healthcare services. The reportable segments are as follows, The Hospital services segment, which generates majority revenue, includes the provision of hospital services including inpatient healthcare services, outpatient healthcare services, and physical examination services; Rehabilitation and other healthcare services including the provision of rehabilitation services; Elderly healthcare services include the provision of elderly healthcare services, including assisted living, adult daycare, longterm care, residential care and hospice care to the aged patients; and Haemodialysis services segment is principally engaged in the operation of haemodialysis outpatient centres. It generates all of its revenue from the PRC.
79GF Score
Get the complete analysis for FRA:E9Q
3-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:E9Q has been successfully added to your 
